PD-L1 Biomarkers
News and reporting on PD-L1 biomarkers.
Hummingbird Diagnostics Developing miRNA-Based Immunotherapy Predictor on Heels of Positive Study
Premium
The company published a pilot study showing that it's five-miRNA signature could predict which lung cancer patients survived longer on immunotherapy treatment.
BostonGene Closes $150M Series B Funding Round
The firm will use the financing to further the development, clinical expansion, and international availability of its Tumor Portrait tests.
EU IVDR Implementation Woes Could Severely Limit Cancer Companion Test, Precision Therapy Access
Premium
The EC has stuck with its timeline to implement the new regulations in eight months, raising concerns for cancer patients' ability to receive biomarker testing and treatments.
Labcorp, CCORN Ink Partnership to Address Precision Oncology Disparities
The Community Clinical Oncology Research Network will leverage Labcorp's comprehensive genomic profiling test to build out a registry of diverse patient data.
Johns Hopkins researchers have developed a single-cell, multispectral imaging platform called AstroPath for precise pathological analysis of cancer specimens.